| 書目名稱 | Twenty Years of G-CSF |
| 副標(biāo)題 | Clinical and Nonclin |
| 編輯 | Graham Molineux,MaryAnn Foote,Tara Arvedson |
| 視頻video | http://file.papertrans.cn/932/931224/931224.mp4 |
| 概述 | Many of the authors are the original investigators of recombinant human G-CSF.Key researchers provide their outlook for the next 20 years.Describes oncological and non-oncological applications.Include |
| 叢書名稱 | Milestones in Drug Therapy |
| 圖書封面 |  |
| 描述 | .Granulocyte colony-stimulating factor (G-CSF or GCSF) is a secreted glycoprotein that stimulates the proliferation and differentiation of granulocyte precursor cells, and induces mobilization of peripheral blood progenitor cells from the bone marrow. Development of recombinant human G-CSF has had a profound impact on the treatment of many diseases, including severe chronic neutropenia and cancer, and has enabled peripheral stem cell transplantation to supplant bone marrow transplantation in the autologous setting. .This .Milestones in Drug Therapy. volume describes the experience of the last 20 years of treatment with recombinant human G-CSF, including the basic science, the use of recombinant human G-CSF in both the oncology and nononcology settings, and the safety and economics of its use. Many of the authors were the original investigators of recombinant human G-CSF and other authors are key researchers who provide their outlook for the next 20 years for use of and research with recombinant human G-CSF.. |
| 出版日期 | Book 2012 |
| 關(guān)鍵詞 | hematopoiesis; infectious diseases; neutropenia; oncology; pharmacology |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-0348-0218-5 |
| isbn_softcover | 978-3-0348-0804-0 |
| isbn_ebook | 978-3-0348-0218-5Series ISSN 2296-6056 Series E-ISSN 2296-6064 |
| issn_series | 2296-6056 |
| copyright | Springer Basel AG 2012 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-27 02:57
發(fā)表于 2025-3-21 19:31:41
